Share
AACR Annual Meeting 2021
Virtual Meeting
April 10, 2021, at 9:00 AM ET - April 15, 2021, at 6:00 PM ETThe AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their boundaries, form collaborations, attend sessions outside their own areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research. At this virtual event, we shared our products and resources supporting cancer research. Feel free to view some of our content around cancer diagnostics and drug development below.
Did you miss the meeting but would still like to speak to one of ATCC’s representatives about a product or service? Make an appointment with us so we can discuss your needs.
Organoid education
Culturing organoids can be intimidating, as these 3D organotypic models require many additional considerations compared to traditional cell growth techniques. To help researchers get their organoids growing, ATCC scientists have used their expertise to create educational materials that contains everything you need to know about the initiation, expansion, and cryopreservation of organoids in embedded 3D culture. Choose from either watching our instructional video on demand, or download the comprehensive organoid culture guide.
Get the resourcesResources for cancer diagnostics and drug development
Luciferase-labeled cell lines
ATCC is bridging the gap between the in vitro and the in vivo by offering luciferase-labeled cell lines for biological mechanism studies and drug development; these advanced models provide a relatively simple, robust, and highly sensitive means to measure biological processes and to assess drug efficacy in live animal models through bioluminescence imaging.
Get started
Next-generation cancer models
ATCC is offering scientists a wide variety of next-generation patient-derived in vitro cancer models, including organoids, which will include both common as well as rare and understudied examples of cancer from numerous tissues. These advanced models are valuable tools to study cancer, identify and target novel therapies, and facilitate translational cancer research.
Discover how
EMT reporter cells
Epithelial-mesenchymal transition (EMT) and its reverse, MET, can play critical roles in promoting metastasis and invasion and contribute to drug resistance in carcinoma. ATCC used CRISPR gene editing to develop new reporter lines designed to enable the real-time monitoring of the changing status of cells from epithelial to mesenchymal.
Enhance your researchCheck out our posters from AACR 2020
Poster
Development of a Novel ECAD-EmGFP Reporter Line for Pancreatic Cancer MET Study and Drug Discovery
This is a poster presented at AACR 2020 that discusses the use of the PANC-1 ECAD-EmGFP reporter line in studying epithelial-to-mesenchymal transition.
More
Poster
Luciferase-expressing Monocyte Reporter Cell Lines as a Predictive Human Cell-Based Model
This is a poster presented at AACR 2020 that discusses the use of THP-1 luciferase reporter cell lines in immuno-oncology research.
MoreAACR Annual Meeting
Your ATCC sales representative stands ready to discuss your research needs and provide you with personalized care. Please complete our form to let us know how we can help, and we will start working on your needs right away.
